Max India shares fell 4 per cent on Wednesday after the company said insurance regulator Irdai has approved the sale of its 51 per cent stake in Max Bupa Health Insurance Company to private equity firm True North.
The scrip declined 3.48 per cent to close at Rs 77.60 on the BSE. During the day, it fell 4.85 per cent to Rs 76.50.
At the NSE, it dropped 3.97 per cent to close at Rs 77.30.
With the deal getting regulatory approval, Max India will exit the health insurance business.
The all-cash transaction announced in February 2019 valued Max Bupa at an enterprise value of Rs 1,001 crore, Max India said in a statement on Tuesday.
Post Irdai's approval, the transaction is now expected to be concluded within few weeks, it said, adding, all existing customer policies will continue unimpacted and all customer support channels will remain unchanged.
True North (formerly known as India Value Fund Advisors - IVFA) was established in 1999 with a focus on investing in and transforming mid-sized profitable businesses into world-class industry leaders.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
